Posterior reversible encephalopathy syndrome following immunoglobulin therapy in a patient with Miller-Fisher syndrome

by Bruno Niemeyer de Freitas Ribeiro, Tiago Medina Salata, Rafael Silveira Borges, Edson Marchiori
Published 2016-02-01

Intravenous immunoglobulin therapy in kidney transplant recipients with de novo DSA: Results of an observational study.

by Marie Matignon, Caroline Pilon, Morgane Commereuc, Cynthia Grondin, Claire Leibler, Tomek Kofman, Vincent Audard, José Cohen, Florence Canoui-Poitrine, Philippe Grimbert
Published 2017-01-01

Proteomic Analysis of Sera from Common Variable Immunodeficiency Patients Undergoing Replacement Intravenous Immunoglobulin Therapy

by Giuseppe Spadaro, Concetta D'Orio, Arturo Genovese, Antonella Galeotafiore, Chiara D'Ambrosio, Stefano Di Giovanni, Monica Vitale, Mario Capasso, Vincenzo Lamberti, Andrea Scaloni, Gianni Marone, Nicola Zambrano
Published 2011-01-01

Phenotypic and Transcriptomic Lymphocytes Changes in Allograft Recipients After Intravenous Immunoglobulin Therapy in Kidney Transplant Recipients

by Caroline Pilon, Caroline Pilon, Caroline Pilon, Jeremy Bigot, Jeremy Bigot, Cynthia Grondin, Allan Thiolat, Allan Thiolat, Philippe Lang, Philippe Lang, Philippe Lang, José L. Cohen, José L. Cohen, José L. Cohen, Philippe Grimbert, Philippe Grimbert, Philippe Grimbert, Philippe Grimbert, Marie Matignon, Marie Matignon, Marie Matignon, Marie Matignon
Published 2020-01-01

A Retrospective Cohort Study of Intravenous Immunoglobulin Therapy in the Acute Phase of Kawasaki Disease: The Earlier, the Better?

by Wei Li, Xiufang He, Li Zhang, Zhouping Wang, Yanfei Wang, Huimei Lin, Jia Yuan, Xiaofei Xie, Youzhen Qin, Ping Huang
Published 2021-01-01

Health-related quality of life in patients with common variable immunodeficiency switching from intravenous to subcutaneous immunoglobulin therapy

by Mona Al-Ahmad, Ahmed Maher, Jasmina Nurkic
Published 2017-01-01

High-dose intravenous immunoglobulin therapy for novel coronavirus disease 2019: a brief report of two cases

by Cem Erdogan, Bahadir Ciftci, Deniz Kizilaslan, Mursel Ekinci, Gülsen İptec, Ali İhsan Gemici, Pelin Karaaslan
Published 2020-09-01

Two comparative assessments of intravenous immunoglobulin therapy switching patterns...

by Guptill JT, Runken MC, Eaddy M, Lunacsek OE, Fuldeore RM, Blanchette CM, Zacherle E, Noone JM
Published 2019-04-01

Clinical and economic outcomes of a "high-touch" clinical management program for intravenous immunoglobulin therapy

by Zhu J, Kirkham HS, Ayer G, Chen CC, Wade RL, Karkare SU, Robson CH, Orange JS
Published 2017-12-01

Crystalline-Like Keratopathy after Intravenous Immunoglobulin Therapy with Incomplete Kawasaki Disease: Case Report and Literature Review

by Elif Erdem, Emine Kocabas, Hande Taylan Sekeroglu, Özlem Özgür, Meltem Yagmur, T. Reha Ersoz
Published 2013-01-01

Hemolytic anemia following intravenous immunoglobulin therapy in patients treated for Kawasaki disease: a report of 4 cases

by Berard Roberta, Whittemore Blair, Scuccimarri Rosie
Published 2012-04-01

CNS Involvement in HIV Infection

by J Gordon Millichap
Published 1991-08-01

In-hospital and post-discharge outcomes of pediatric acute myocarditis underwent after high-dose steroid or intravenous immunoglobulin therapy

by Ming-Shyan Lin, Yu-Hsiang Tseng, Mei-Yen Chen, Chang-Min Chung, Ming-Horng Tsai, Po-Chang Wang, Jung-Jung Chang, Tien-Hsing Chen, Yu-Sheng Lin
Published 2019-01-01

Clinical efficacy of intravenous immunoglobulin therapy in critical ill patients with COVID‐19: a multicenter retrospective cohort study

by Ziyun Shao, Yongwen Feng, Li Zhong, Qifeng Xie, Ming Lei, Zheying Liu, Conglin Wang, Jingjing Ji, Huiheng Liu, Zhengtao Gu, Zhongwei Hu, Lei Su, Ming Wu, Zhifeng Liu
Published 2020-01-01

Role of intravenous immunoglobulin therapy in the survival rate of pediatric patients with acute myocarditis: A systematic review and meta-analysis

by Chun-Yu Yen, Miao-Chiu Hung, Ying-Chi Wong, Chia-Yuan Chang, Chou-Cheng Lai, Keh-Gong Wu
Published 2019-07-01

Cerebellar ataxia associated to anti-glutamic acid decarboxylase autoantibody (anti-GAD): partial improvement with intravenous immunoglobulin therapy

by José Luiz Pedroso, Pedro Braga-Neto, Livia Almeida Dutra, Orlando G.P. Barsottini
Published 2011-12-01

Effectiveness of high‐dose i.v. immunoglobulin therapy for pregnant women with aspirin–heparin‐resistant secondary antiphospholipid syndrome

by Yoko Maesawa, Masashi Deguchi, Kenji Tanimura, Mayumi Morizane, Yasuhiko Ebina, Hideto Yamada
Published 2018-04-01

Acute Onset Infantile Spinal Muscular Atrophy

by J Gordon Millichap
Published 2001-07-01

A low-frequency IL4R locus variant in Japanese patients with intravenous immunoglobulin therapy-unresponsive Kawasaki disease

by Yuji Amano, Yohei Akazawa, Jun Yasuda, Kazuhisa Yoshino, Katsuhiko Kojima, Norimoto Kobayashi, Satoshi Matsuzaki, Masao Nagasaki, Yosuke Kawai, Naoko Minegishi, Noriko Ishida, Noriko Motoki, Akira Hachiya, Yozo Nakazawa, Masayuki Yamamoto, Kenichi Koike, Toshikazu Takeshita
Published 2019-07-01

Effect of Immunoglobulin Therapy on the Rate of Infections in Multiple Myeloma Patients Undergoing...

by Gerald Bates, Burns Denise, Amanda Cox, Matthias Maiwald, Alhossain A. Khalafallah, Terry Hannan, David Seaton, Bernadene Fernandopulle, Terry Brain
Published 2010-02-01